Yale School of Medicine and medical marijuana provider CT Pharma has obtained approval from the Food and Drug Administration to conduct a human study on the effectiveness of marijuana-based medicine.
The lead researcher behind the clinical trial is Dr. Rajita Sinha.
“How does it work, who does it work for, and what doses do you need?” are the questions researchers hope to answer, she said during a news conference about the trial, according to The CT Mirror.
“Which symptoms can be alleviated, and is there a need for refinement? There are so many questions.”
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers